Salta al contenuto
Universidad del Mar SIBUMAR Descubridor Institucional UMAR
  • Inicio
  • Búsqueda avanzada
  • Explorar
  • Entra
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
Avanzata
  • 188 | INFLUENCE OF TP53 GENE ALTERATIONS IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA TREATED WITH BISPECIFIC ANTIBODIES
Copertina

188 | INFLUENCE OF TP53 GENE ALTERATIONS IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA TREATED WITH BISPECIFIC ANTIBODIES

Fuente: Wiley Open Access
Salvato in:
Dettagli Bibliografici
Autori principali: M. Bosch Schips, M. Erguin Gamazo, P. Acha González, V. Navarro Garcés, L. Caritá, J. Castellví Vives, J. Iraola Truchuelo, G. Losi, C. Pagés Geli, A. Jerez Cayuela, M. Gabarrós Subirá, A. Blanco, S. Novoa‐Jauregui, F. Beas Hurtado, J. Méndez, Á. Arnaldos López, Á. Serna Pareja, C. García Herce, S. Feijóo Monroy, M. Sánchez Salinas, C. Carpio, G. I. Iacoboni García‐Calvo, A. Marín‐Niebla, P. Barba Suñol, A. Mussetti, F. Bosch Albareda, M. Crespo Maull, P. Abrisqueta Costa
Natura: Artículo Open Access
Pubblicazione: Wiley 2025
Soggetti:
Hematological Oncology
Accesso online:
Acceder al recurso
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
  • Citazione
  • Invia SMS
  • Invia email
  • Stampa
  • Esporta il record
    • Esporta a RefWorks
    • Esporta a EndNoteWeb
    • Esporta a EndNote
  • Aggiungi alla lista
  • PLink permanente
  • Posseduto
  • Descrizione
  • Commenti
  • Documenti analoghi
  • MARC21

Accesso online

https://onlinelibrary.wiley.com/doi/10.1002/hon.70094_188

Documenti analoghi

  • 707 | CLINICAL OUTCOMES WITH BISPECIFIC ANTIBODIES IN THE MANAGEMENT OF SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA
    di: N. K. Dave, et al.
    Pubblicazione: (2025)
  • 264 | CD3XCD20 BISPECIFIC ANTIBODIES IN TRANSFORMED WALDENSTRÖM MACROGLOBULINEMIA/LYMPHOPLASMACYTIC LYMPHOMA
    di: M. Brocard, et al.
    Pubblicazione: (2025)
  • 637 | THE NON‐STANDARD ROLE OF BISPECIFIC ANTIBODIES IN THE TREATMENT ALGORITHM OF RELAPSED/REFRACTORY DLBCL IN COUNTRIES WITHOUT CART. ARGENTINE EXPERIENCE WITH EPCORITAMAB
    di: C. Mahuad, et al.
    Pubblicazione: (2025)
  • 663 | PATIENT PREFERENCES FOR ATTRIBUTES OF BISPECIFIC ANTIBODIES INDICATED FOR THE TREATMENT OF RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA IN THE UNITED STATES
    di: E. Mulvey, et al.
    Pubblicazione: (2025)
  • 882 | CHARACTERISTICS OF SECOND PRIMARY MALIGNANCIES FOLLOWING BISPECIFIC ANTIBODIES THERAPY
    di: X. Liang, et al.
    Pubblicazione: (2025)
Universidad del Mar
Universidad del MarSistema Bibliotecario de la Universidad del MarDescubridor Institucional UMARImplementación y desarrollo: Mtro. Carlos Alonso Albores Pérez
InicioBúsqueda avanzadaExplorar
Visitas al Descubridor: 387,319© 2026 Universidad del Mar